Edwards Lifesciences Corporation Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2024: USD -1.06 B

Edwards Lifesciences Corporation Common Stock Repurchased is USD -1.06 B for the Trailing 12 Months (TTM) ending December 31, 2024, a 20.44% change year over year. Common stock repurchased is cash used to buy back the company’s own shares from the market.
  • Edwards Lifesciences Corporation Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -879.60 M, a -49.07% change year over year.
  • Edwards Lifesciences Corporation Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -1.73 B, a 236.80% change year over year.
  • Edwards Lifesciences Corporation Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2021 was USD -512.80 M, a -18.00% change year over year.
  • Edwards Lifesciences Corporation Common Stock Repurchased for the Trailing 12 Months (TTM) ending December 31, 2020 was USD -625.40 M.
Key Data
Date Common Stock Repurchased Free Cash Flow Operating Cash Flow Capital Expenditure